IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-024-49944-0.html
   My bibliography  Save this article

Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer

Author

Listed:
  • Suzanne J. Forrest

    (Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
    Harvard Medical School)

  • Hersh Gupta

    (Dana-Farber Cancer Institute
    Broad Institute of MIT and Harvard)

  • Abigail Ward

    (Dana-Farber/Boston Children’s Cancer and Blood Disorders Center)

  • Yvonne Y. Li

    (Dana-Farber Cancer Institute
    Broad Institute of MIT and Harvard)

  • Duong Doan

    (Dana-Farber/Boston Children’s Cancer and Blood Disorders Center)

  • Alyaa Al-Ibraheemi

    (Harvard Medical School
    Boston Children’s Hospital)

  • Sanda Alexandrescu

    (Harvard Medical School
    Boston Children’s Hospital)

  • Pratiti Bandopadhayay

    (Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
    Harvard Medical School)

  • Suzanne Shusterman

    (Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
    Harvard Medical School)

  • Elizabeth A. Mullen

    (Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
    Harvard Medical School)

  • Natalie B. Collins

    (Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
    Harvard Medical School)

  • Susan N. Chi

    (Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
    Harvard Medical School)

  • Karen D. Wright

    (Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
    Harvard Medical School)

  • Priti Kumari

    (Dana-Farber Cancer Institute)

  • Tali Mazor

    (Dana-Farber Cancer Institute)

  • Keith L. Ligon

    (Harvard Medical School
    Dana-Farber Cancer Institute
    Boston Children’s Hospital
    Brigham and Women’s Hospital)

  • Priyanka Shivdasani

    (Brigham and Women’s Hospital)

  • Monica Manam

    (Boston Children’s Hospital)

  • Laura E. MacConaill

    (Brigham and Women’s Hospital)

  • Evelina Ceca

    (Dana-Farber/Boston Children’s Cancer and Blood Disorders Center)

  • Sidney N. Benich

    (Dana-Farber/Boston Children’s Cancer and Blood Disorders Center)

  • Wendy B. London

    (Dana-Farber/Boston Children’s Cancer and Blood Disorders Center)

  • Richard L. Schilsky

    (American Society of Clinical Oncology)

  • Suanna S. Bruinooge

    (American Society of Clinical Oncology)

  • Jaime M. Guidry Auvil

    (National Cancer Institute)

  • Ethan Cerami

    (Dana-Farber Cancer Institute)

  • Barrett J. Rollins

    (Harvard Medical School
    Dana-Farber Cancer Institute
    Brigham and Women’s Hospital)

  • Matthew L. Meyerson

    (Harvard Medical School
    Dana-Farber Cancer Institute
    Broad Institute of MIT and Harvard)

  • Neal I. Lindeman

    (Weill Cornell Medical College)

  • Bruce E. Johnson

    (Harvard Medical School
    Dana-Farber Cancer Institute
    Brigham and Women’s Hospital)

  • Andrew D. Cherniack

    (Dana-Farber Cancer Institute
    Broad Institute of MIT and Harvard)

  • Alanna J. Church

    (Harvard Medical School
    Boston Children’s Hospital)

  • Katherine A. Janeway

    (Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
    Harvard Medical School)

Abstract

To inform clinical trial design and real-world precision pediatric oncology practice, we classified diagnoses, assessed the landscape of mutations, and identified genomic variants matching trials in a large unselected institutional cohort of solid tumors patients sequenced at Dana-Farber / Boston Children’s Cancer and Blood Disorders Center. Tumors were sequenced with OncoPanel, a targeted next-generation DNA sequencing panel. Diagnoses were classified according to the International Classification of Diseases for Oncology (ICD-O-3.2). Over 6.5 years, 888 pediatric cancer patients with 95 distinct diagnoses had successful tumor sequencing. Overall, 33% (n = 289/888) of patients had at least 1 variant matching a precision oncology trial protocol, and 14% (41/289) were treated with molecularly targeted therapy. This study highlights opportunities to use genomic data from hospital-based sequencing performed either for research or clinical care to inform ongoing and future precision oncology clinical trials. Furthermore, the study results emphasize the importance of data sharing to define the genomic landscape and targeted treatment opportunities for the large group of rare pediatric cancers we encounter in clinical practice.

Suggested Citation

  • Suzanne J. Forrest & Hersh Gupta & Abigail Ward & Yvonne Y. Li & Duong Doan & Alyaa Al-Ibraheemi & Sanda Alexandrescu & Pratiti Bandopadhayay & Suzanne Shusterman & Elizabeth A. Mullen & Natalie B. Co, 2024. "Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer," Nature Communications, Nature, vol. 15(1), pages 1-11, December.
    • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-49944-0
    DOI: 10.1038/s41467-024-49944-0
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-49944-0
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-024-49944-0?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Xiaotu Ma & Yu Liu & Yanling Liu & Ludmil B. Alexandrov & Michael N. Edmonson & Charles Gawad & Xin Zhou & Yongjin Li & Michael C. Rusch & John Easton & Robert Huether & Veronica Gonzalez-Pena & Mark , 2018. "Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours," Nature, Nature, vol. 555(7696), pages 371-376, March.
    2. Susanne N. Gröbner & Barbara C. Worst & Joachim Weischenfeldt & Ivo Buchhalter & Kortine Kleinheinz & Vasilisa A. Rudneva & Pascal D. Johann & Gnana Prakash Balasubramanian & Maia Segura-Wang & Sebast, 2018. "The landscape of genomic alterations across childhood cancers," Nature, Nature, vol. 555(7696), pages 321-327, March.
    3. Konrad J. Karczewski & Laurent C. Francioli & Grace Tiao & Beryl B. Cummings & Jessica Alföldi & Qingbo Wang & Ryan L. Collins & Kristen M. Laricchia & Andrea Ganna & Daniel P. Birnbaum & Laura D. Gau, 2020. "The mutational constraint spectrum quantified from variation in 141,456 humans," Nature, Nature, vol. 581(7809), pages 434-443, May.
    4. Susanne N. Gröbner & Barbara C. Worst & Joachim Weischenfeldt & Ivo Buchhalter & Kortine Kleinheinz & Vasilisa A. Rudneva & Pascal D. Johann & Gnana Prakash Balasubramanian & Maia Segura-Wang & Sebast, 2018. "Author Correction: The landscape of genomic alterations across childhood cancers," Nature, Nature, vol. 559(7714), pages 10-10, July.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Yanling Liu & Jonathon Klein & Richa Bajpai & Li Dong & Quang Tran & Pandurang Kolekar & Jenny L. Smith & Rhonda E. Ries & Benjamin J. Huang & Yi-Cheng Wang & Todd A. Alonzo & Liqing Tian & Heather L., 2023. "Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    2. Ting Liu & Jianan Rao & Wenting Hu & Bowen Cui & Jiaoyang Cai & Yuhan Liu & Huiying Sun & Xiaoxiao Chen & Yanjing Tang & Jing Chen & Xiang Wang & Han Wang & Wubin Qian & Binchen Mao & Sheng Guo & Rong, 2022. "Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    3. Albert Stuart Reece & Gary Kenneth Hulse, 2022. "Epidemiology of Δ8THC-Related Carcinogenesis in USA: A Panel Regression and Causal Inferential Study," IJERPH, MDPI, vol. 19(13), pages 1-27, June.
    4. Yong Yean Kim & Berkley E. Gryder & Ranuka Sinniah & Megan L. Peach & Jack F. Shern & Abdalla Abdelmaksoud & Silvia Pomella & Girma M. Woldemichael & Benjamin Z. Stanton & David Milewski & Joseph J. B, 2024. "KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
    5. Ulrik Kristoffer Stoltze & Jon Foss-Skiftesvik & Thomas van Overeem Hansen & Simon Rasmussen & Konrad J. Karczewski & Karin A. W. Wadt & Kjeld Schmiegelow, 2024. "The evolutionary impact of childhood cancer on the human gene pool," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    6. Sara G. Danielli & Yun Wei & Michael A. Dyer & Elizabeth Stewart & Heather Sheppard & Marco Wachtel & Beat W. Schäfer & Anand G. Patel & David M. Langenau, 2024. "Single cell transcriptomic profiling identifies tumor-acquired and therapy-resistant cell states in pediatric rhabdomyosarcoma," Nature Communications, Nature, vol. 15(1), pages 1-14, December.
    7. Joanna Szydzik & Dan E. Lind & Badrul Arefin & Yeshwant Kurhe & Ganesh Umapathy & Joachim Tetteh Siaw & Arne Claeys & Jonatan L. Gabre & Jimmy Eynden & Bengt Hallberg & Ruth H. Palmer, 2021. "ATR inhibition enables complete tumour regression in ALK-driven NB mouse models," Nature Communications, Nature, vol. 12(1), pages 1-18, December.
    8. Samuel Rivero-Hinojosa & Melanie Grant & Aswini Panigrahi & Huizhen Zhang & Veronika Caisova & Catherine M. Bollard & Brian R. Rood, 2021. "Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors," Nature Communications, Nature, vol. 12(1), pages 1-15, December.
    9. Albert Stuart Reece & Gary Kenneth Hulse, 2022. "Epigenomic and Other Evidence for Cannabis-Induced Aging Contextualized in a Synthetic Epidemiologic Overview of Cannabinoid-Related Teratogenesis and Cannabinoid-Related Carcinogenesis," IJERPH, MDPI, vol. 19(24), pages 1-57, December.
    10. Jie Fang & Shivendra Singh & Changde Cheng & Sivaraman Natarajan & Heather Sheppard & Ahmed Abu-Zaid & Adam D. Durbin & Ha Won Lee & Qiong Wu & Jacob Steele & Jon P. Connelly & Hongjian Jin & Wenan Ch, 2023. "Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastoma," Nature Communications, Nature, vol. 14(1), pages 1-27, December.
    11. Hanbing Song & Simon Bucher & Katherine Rosenberg & Margaret Tsui & Deviana Burhan & Daniel Hoffman & Soo-Jin Cho & Arun Rangaswami & Marcus Breese & Stanley Leung & María V. Pons Ventura & E. Alejand, 2022. "Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    12. John K. L. Wong & Christian Aichmüller & Markus Schulze & Mario Hlevnjak & Shaymaa Elgaafary & Peter Lichter & Marc Zapatka, 2022. "Association of mutation signature effectuating processes with mutation hotspots in driver genes and non-coding regions," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
    13. Vincent Michaud & Eulalie Lasseaux & David J. Green & Dave T. Gerrard & Claudio Plaisant & Tomas Fitzgerald & Ewan Birney & Benoît Arveiler & Graeme C. Black & Panagiotis I. Sergouniotis, 2022. "The contribution of common regulatory and protein-coding TYR variants to the genetic architecture of albinism," Nature Communications, Nature, vol. 13(1), pages 1-8, December.
    14. Natalie DeForest & Yuqi Wang & Zhiyi Zhu & Jacqueline S. Dron & Ryan Koesterer & Pradeep Natarajan & Jason Flannick & Tiffany Amariuta & Gina M. Peloso & Amit R. Majithia, 2024. "Genome-wide discovery and integrative genomic characterization of insulin resistance loci using serum triglycerides to HDL-cholesterol ratio as a proxy," Nature Communications, Nature, vol. 15(1), pages 1-17, December.
    15. Alexendar R. Perez & Laura Sala & Richard K. Perez & Joana A. Vidigal, 2021. "CSC software corrects off-target mediated gRNA depletion in CRISPR-Cas9 essentiality screens," Nature Communications, Nature, vol. 12(1), pages 1-11, December.
    16. Michel S. Naslavsky & Marilia O. Scliar & Guilherme L. Yamamoto & Jaqueline Yu Ting Wang & Stepanka Zverinova & Tatiana Karp & Kelly Nunes & José Ricardo Magliocco Ceroni & Diego Lima Carvalho & Carlo, 2022. "Whole-genome sequencing of 1,171 elderly admixed individuals from Brazil," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    17. Nicole Deflaux & Margaret Sunitha Selvaraj & Henry Robert Condon & Kelsey Mayo & Sara Haidermota & Melissa A. Basford & Chris Lunt & Anthony A. Philippakis & Dan M. Roden & Joshua C. Denny & Anjene Mu, 2023. "Demonstrating paths for unlocking the value of cloud genomics through cross cohort analysis," Nature Communications, Nature, vol. 14(1), pages 1-10, December.
    18. Andrea Wilderman & Eva D’haene & Machteld Baetens & Tara N. Yankee & Emma Wentworth Winchester & Nicole Glidden & Ellen Roets & Jo Dorpe & Sandra Janssens & Danny E. Miller & Miranda Galey & Kari M. B, 2024. "A distant global control region is essential for normal expression of anterior HOXA genes during mouse and human craniofacial development," Nature Communications, Nature, vol. 15(1), pages 1-23, December.
    19. Ruoyu Tian & Tian Ge & Hyeokmoon Kweon & Daniel B. Rocha & Max Lam & Jimmy Z. Liu & Kritika Singh & Daniel F. Levey & Joel Gelernter & Murray B. Stein & Ellen A. Tsai & Hailiang Huang & Christopher F., 2024. "Whole-exome sequencing in UK Biobank reveals rare genetic architecture for depression," Nature Communications, Nature, vol. 15(1), pages 1-12, December.
    20. Mary-Ellen Lynall & Blagoje Soskic & James Hayhurst & Jeremy Schwartzentruber & Daniel F. Levey & Gita A. Pathak & Renato Polimanti & Joel Gelernter & Murray B. Stein & Gosia Trynka & Menna R. Clatwor, 2022. "Genetic variants associated with psychiatric disorders are enriched at epigenetically active sites in lymphoid cells," Nature Communications, Nature, vol. 13(1), pages 1-15, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-49944-0. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.